ATE237806T1 - Neue reagenzien und methoden zur lyse von erythrozyten - Google Patents

Neue reagenzien und methoden zur lyse von erythrozyten

Info

Publication number
ATE237806T1
ATE237806T1 AT99430007T AT99430007T ATE237806T1 AT E237806 T1 ATE237806 T1 AT E237806T1 AT 99430007 T AT99430007 T AT 99430007T AT 99430007 T AT99430007 T AT 99430007T AT E237806 T1 ATE237806 T1 AT E237806T1
Authority
AT
Austria
Prior art keywords
erythrocytes
lysis
methods
new reagents
nitrogen containing
Prior art date
Application number
AT99430007T
Other languages
English (en)
Inventor
Agthoven Andre Van
David Jarrossay
Original Assignee
Immunotech Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunotech Sa filed Critical Immunotech Sa
Application granted granted Critical
Publication of ATE237806T1 publication Critical patent/ATE237806T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497Preparation composition [e.g., lysing or precipitation, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331Preservative, buffer, anticoagulant or diluent

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Ecology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT99430007T 1998-05-07 1999-05-04 Neue reagenzien und methoden zur lyse von erythrozyten ATE237806T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9806055A FR2778413B1 (fr) 1998-05-07 1998-05-07 Nouveaux reactifs et methode de lyse des erythrocytes

Publications (1)

Publication Number Publication Date
ATE237806T1 true ATE237806T1 (de) 2003-05-15

Family

ID=9526319

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99430007T ATE237806T1 (de) 1998-05-07 1999-05-04 Neue reagenzien und methoden zur lyse von erythrozyten

Country Status (11)

Country Link
US (1) US6143567A (de)
EP (1) EP0955543B1 (de)
JP (2) JPH11352125A (de)
AT (1) ATE237806T1 (de)
AU (1) AU747910B2 (de)
DE (2) DE69906859T2 (de)
ES (1) ES2141073T1 (de)
FR (1) FR2778413B1 (de)
GR (1) GR990300041T1 (de)
NO (1) NO992206L (de)
NZ (1) NZ335594A (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2813891B1 (fr) * 2000-09-14 2005-01-14 Immunotech Sa Reactif multifonctionnel pour erythrocytes mettant en jeu des carbamates et applications
US7465584B2 (en) * 2005-01-24 2008-12-16 Sysmex Corporation Method and reagent for classifying leukocytes in animal blood
DK3035798T3 (en) * 2013-08-20 2018-11-19 Univ Yeditepe CELL CRYO-CONSERVATION MEDIUM ADDED TO DRILL
US10577627B2 (en) 2014-06-09 2020-03-03 Voyager Therapeutics, Inc. Chimeric capsids
MX2017005834A (es) 2014-11-05 2017-11-17 Voyager Therapeutics Inc Polinucleotidos aad para el tratamiento de la enfermedad de parkinson.
RU2749882C2 (ru) 2014-11-14 2021-06-18 Вояджер Терапьютикс, Инк. Модулирующие полинуклеотиды
EP3218484A4 (de) 2014-11-14 2018-05-30 Voyager Therapeutics, Inc. Zusammensetzungen und verfahren zur behandlung von amyotropher lateralsklerose (als)
US11697825B2 (en) 2014-12-12 2023-07-11 Voyager Therapeutics, Inc. Compositions and methods for the production of scAAV
US20180230489A1 (en) 2015-10-28 2018-08-16 Voyager Therapeutics, Inc. Regulatable expression using adeno-associated virus (aav)
WO2017078672A1 (en) 2015-11-02 2017-05-11 Chiranjit Deka Light scatter based apparatus and methods for hematology analysis using only three detectors
EP3448874A4 (de) 2016-04-29 2020-04-22 Voyager Therapeutics, Inc. Zusammensetzungen zur behandlung einer erkrankung
US11299751B2 (en) 2016-04-29 2022-04-12 Voyager Therapeutics, Inc. Compositions for the treatment of disease
RU2758488C2 (ru) 2016-05-18 2021-10-28 Вояджер Терапьютикс, Инк. Модулирующие полинуклеотиды
JP7220080B2 (ja) 2016-05-18 2023-02-09 ボイジャー セラピューティクス インコーポレイテッド ハンチントン病治療組成物及び方法
EP3506817A4 (de) 2016-08-30 2020-07-22 The Regents of The University of California Verfahren für biomedizinisches targeting und freisetzung sowie vorrichtungen und systeme zur ausführung davon
WO2018048586A1 (en) * 2016-09-06 2018-03-15 Chiranjit Deka Improved reagent and method for identification and enumeration of basophils
WO2018204786A1 (en) 2017-05-05 2018-11-08 Voyager Therapeutics, Inc. Compositions and methods of treating amyotrophic lateral sclerosis (als)
WO2018204803A1 (en) 2017-05-05 2018-11-08 Voyager Therapeutics, Inc. Compositions and methods of treating huntington's disease
WO2018220835A1 (ja) * 2017-06-02 2018-12-06 日立化成株式会社 血液試料中の希少細胞を分離する方法及び該細胞の遺伝子を解析する方法
JOP20190269A1 (ar) 2017-06-15 2019-11-20 Voyager Therapeutics Inc بولي نوكليوتيدات aadc لعلاج مرض باركنسون
JP7229989B2 (ja) 2017-07-17 2023-02-28 ボイジャー セラピューティクス インコーポレイテッド 軌道アレイガイドシステム
EP3662060A2 (de) 2017-08-03 2020-06-10 Voyager Therapeutics, Inc. Zusammensetzungen und verfahren zur aav-freisetzung
EP3441763A1 (de) 2017-08-08 2019-02-13 Euroimmun Medizinische Labordiagnostika AG Verfahren zum nachweis einer basophilenaktivierung
BR102018015288A2 (pt) 2017-08-08 2021-11-09 Euroimmun Medizinische Labordiagnostika Ag Método para comprovar uma ativação de basófilos
EP3697908A1 (de) 2017-10-16 2020-08-26 Voyager Therapeutics, Inc. Behandlung von amyotropher lateralsklerose (als)
EP4124658A3 (de) 2017-10-16 2023-04-19 Voyager Therapeutics, Inc. Behandlung von amyotropher lateralsklerose (als)
EP3762500A1 (de) 2018-03-06 2021-01-13 Voyager Therapeutics, Inc. Aus insektenzelle hergestellte teilweise selbstkomplementäre aav-genome
WO2019222441A1 (en) 2018-05-16 2019-11-21 Voyager Therapeutics, Inc. Aav serotypes for brain specific payload delivery
WO2019222444A2 (en) 2018-05-16 2019-11-21 Voyager Therapeutics, Inc. Directed evolution
JP7565218B2 (ja) 2018-07-02 2024-10-10 ボイジャー セラピューティクス インコーポレイテッド 筋萎縮性側索硬化症および脊髄に関連する障害の治療
US20210355454A1 (en) 2018-07-24 2021-11-18 Voyager Therapeutics, Inc. Systems and methods for producing gene therapy formulations
US20210348242A1 (en) 2018-10-04 2021-11-11 Voyager Therapeutics, Inc. Methods for measuring the titer and potency of viral vector particles
US20220064671A1 (en) 2019-01-18 2022-03-03 Voyager Therapeutics, Inc. Methods and systems for producing aav particles
EP3962536A1 (de) 2019-04-29 2022-03-09 Voyager Therapeutics, Inc. Systeme und verfahren zur herstellung von baculovirusinfizierten insektenzellen (biics) in bioreaktoren
EP4010465A1 (de) 2019-08-09 2022-06-15 Voyager Therapeutics, Inc. Zellkulturmedium zur verwendung bei der herstellung von gentherapieprodukten in bioreaktoren
US20220364114A1 (en) 2019-08-26 2022-11-17 Voyager Therapeutics, Inc. Controlled expression of viral proteins
CN111504887B (zh) * 2020-05-09 2023-05-09 苏州四正柏生物科技有限公司 一种溶血素及其制备方法
WO2022032153A1 (en) 2020-08-06 2022-02-10 Voyager Therapeutics, Inc. Cell culture medium for use in producing gene therapy products in bioreactors
US20240141378A1 (en) 2021-03-03 2024-05-02 Voyager Therapeutics, Inc. Controlled expression of viral proteins
WO2022187473A2 (en) 2021-03-03 2022-09-09 Voyager Therapeutics, Inc. Controlled expression of viral proteins
WO2024054983A1 (en) 2022-09-08 2024-03-14 Voyager Therapeutics, Inc. Controlled expression of viral proteins

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3884579A (en) * 1973-06-14 1975-05-20 Cambridge Chemical Products In Method for counting blood platelets
US4284412A (en) * 1979-07-13 1981-08-18 Ortho Diagnostics, Inc. Method and apparatus for automated identification and enumeration of specified blood cell subclasses
US4637986A (en) * 1983-08-22 1987-01-20 Ortho Diagnostic Systems, Inc. Flow cytometry lysing reagent with leukoprotective agent for producing a 3-part WBC count
US4902613A (en) * 1984-05-14 1990-02-20 Becton, Dickinson And Company Lysing agent for analysis of peripheral blood cells
US5188935A (en) * 1984-05-31 1993-02-23 Coulter Electronics, Inc. Reagent system and method for identification, enumeration and examination of classes and subclasses of blood leukocytes
JP2836865B2 (ja) * 1989-10-23 1998-12-14 東亜医用電子株式会社 血液中の白血球およびヘモグロビンの測定用試薬
US5316951A (en) * 1991-06-07 1994-05-31 Carver Jr Edward L Method for the improved determination of white blood cell subpopulations
JP3177863B2 (ja) * 1992-07-17 2001-06-18 東ソー株式会社 不安定型糖化ヘモグロビンの除去方法
DE69434942T2 (de) * 1993-02-25 2007-11-29 Abbott Laboratories, Abbott Park Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben
FR2705360B1 (fr) * 1993-05-19 1995-08-18 Immunotech Sa Méthode et composition pour la lyse des érythrocytes, composition de sang, et méthode d'analyse leucocytaire.
FR2705359B1 (fr) * 1993-05-19 1995-08-18 Immunotech Sa Méthode de protection des cellules leucocytaires, composition protectrice, composition de sang protégée, et méthode d'analyse sanguine.
JPH08189924A (ja) * 1994-03-07 1996-07-23 Sekisui Chem Co Ltd 安定型糖化ヘモグロビンの測定方法
JP3324050B2 (ja) * 1994-10-31 2002-09-17 日本光電工業株式会社 白血球分類用試薬および白血球分類方法
US5763280A (en) * 1997-01-21 1998-06-09 Coulter International Corp. Cyanide-free lytic reagent composition and method for hemoglobin and cell analysis
JP3830613B2 (ja) * 1997-04-18 2006-10-04 シスメックス株式会社 血液中の白血球及びヘモグロビン濃度測定試薬
US6596706B1 (en) * 1997-11-07 2003-07-22 Daiichi Pharmaceutical Co., Ltd. Piperazine-cyclodextrin complexes

Also Published As

Publication number Publication date
FR2778413B1 (fr) 2000-08-04
EP0955543B1 (de) 2003-04-16
US6143567A (en) 2000-11-07
JP4446059B2 (ja) 2010-04-07
JP2008224696A (ja) 2008-09-25
JPH11352125A (ja) 1999-12-24
GR990300041T1 (en) 2000-01-31
NO992206D0 (no) 1999-05-06
AU2698499A (en) 2000-04-13
DE955543T1 (de) 2000-06-08
DE69906859T2 (de) 2004-01-29
DE69906859D1 (de) 2003-05-22
NO992206L (no) 1999-11-08
NZ335594A (en) 2000-02-28
AU747910B2 (en) 2002-05-30
EP0955543A1 (de) 1999-11-10
ES2141073T1 (es) 2000-03-16
FR2778413A1 (fr) 1999-11-12

Similar Documents

Publication Publication Date Title
ATE237806T1 (de) Neue reagenzien und methoden zur lyse von erythrozyten
ATE450794T1 (de) Carbamatenthaltendes multifunktionelles erythrozytenreagenz und verwendungen
ATE36457T1 (de) Verfahren zur inaktivierung von vermehrungsfaehigen krankheitserregern.
KR890702035A (ko) 박테리아 측정을 위한 시료의 제조기법
DE3751109D1 (de) Reagenzien zur Bestimmung von Peptidoglykan und beta-1,3-Glukan.
DE69903236D1 (de) Reagenz zum Assay von Hämoglobin und zur Bestimmung der Leukozyten in einer Blutprobe
HK1085010A1 (en) Latex reagent for adiponectin analysis and method of adiponectin analysis
PT696642E (pt) Processo para a identificacao de pertuebacoes do sistema proteina c / proteina s
ATE271220T1 (de) Borathaltige speicherpuffer und probenverdünner
ATE12318T1 (de) Verfahren und reagenz zur bestimmung von glykosiliertem haemoglobin.
ATE145991T1 (de) Verwendung von lithiumsalzen zur lysis von erythrozyten und zur denaturierung von hämoglobin
DE3784528D1 (de) Zusammensetzung und verfahren zur stabilisierung von dinukleotiden.
DK56386D0 (da) Reagens til ved haemagglunitation at bestemme antistoffer mod bakterielle toksiner, fremgangsmaade til fremstilling af reagenset og dettes anvendelse
ATE56990T1 (de) Verfahren und reagenz zur bestimmung von gesamt- bilirubin.
DE3874611D1 (de) Verfahren und reagens zur bestimmung von ld-1-isoenzym.
ES2084628T3 (es) Metodo enzimatico para determinar las concentraciones del producto analizado.
DE69903380D1 (de) Reagenz und Methode zur Permeabilisierung und zur Identifizierung von Erythrozyten
DK0625707T3 (da) Fremgangsmåde og præparat til lyse af erytrocytter, blodpræparat og fremgangsmåde til leukocytanalyse
DE59205827D1 (de) Verfahren zur Bestimmung von Fibrin
DE3685922D1 (de) Verfahren und reagenz zur beseitigung der stoerung der analyt-wiederfindung in plasmaproben.
ATE205048T1 (de) Konservierungsmittelmischung für diagnostische testflüssigkeiten
GEP19970879B (en) Method for Determining Lead Contents in blood

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0955543

Country of ref document: EP

REN Ceased due to non-payment of the annual fee